Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

Timothy E Albertson,1,2 Willis S Bowman,1,2 Richart W Harper,1,2 Regina M Godbout,2,3 Susan Murin1,21Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, UC Davis, Sacramento, CA, USA; 2Department of Veterans Affairs, Northern California Health Care System, Mathe...

Full description

Bibliographic Details
Main Authors: Albertson TE, Bowman WS, Harper RW, Godbout RM, Murin S
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:International Journal of COPD
Subjects:
Fixed-dose combination inhalers
long-acting beta2-adrenergic agonists (LABA)
long-acting muscarinic antagonists (LAMA)
COPD
umeclidinium bromide
vilanterol trifenatate
Online Access:https://www.dovepress.com/evidence-based-review-of-data-on-the-combination-inhaler-umeclidiniumv-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/evidence-based-review-of-data-on-the-combination-inhaler-umeclidiniumv-peer-reviewed-article-COPD

Similar Items